Solomon Tesfaye

Sheffield Teaching Hospitals & University of Sheffield, UK

Solomon Tesfaye is a Consultant Physician/Endocrinologist at Sheffield Teaching Hospitals and Honorary Professor of Diabetic Medicine at the University of Sheffield, UK. He qualified as a doctor at the University of Bristol in 1984 and trained in diabetes and diabetic neuropathy under Professor JD Ward. His research projects include the epidemiology, risk factors, pathogenesis, central nervous system involvement and treatment of diabetic neuropathy and neuropathic pain. He has published a book, over 150 original articles, reviews and book chapters in the field of diabetic neuropathy including a landmark study in the New England Journal of Medicine. He has received research funding from Diabetes UK, the US National Institute of Health (NIH), Juvenile Diabetes Research Foundation (JDRF), European Foundation for the Study of Diabetes and the UK National Institute for Health Research.

Professor Tesfaye was awarded the Prestigious Camillo Golgi Prize of the European Association for the Study of Diabetes (EASD) in 2014 for major scientific contributions in Diabetic Neuropathy. Professor Tesfaye has had international leadership roles including chairmanship of the International Expert Group on Diabetic Neuropathy that published 7 consensus recommendation papers in 2010/11, and of NEURODIAB (2006-9) which is the largest diabetic neuropathy scientific group in the world. He is also the current Vice Chairman of the Science and Research Committee of Diabetes UK; a Board Member of the Global Quantitative Sensation Testing Society; a member of the Advisory Council of the Neuropathy Trust and Secretary of International Insulin Foundation. He is currently the Associate Editor of Experimental Diabetes Research, Frontiers in Endocrinology, European Endocrinology and Diabetes Management and was previous Associate Editor of Diabetologia. Professor Tesfaye has served as a member of the JDRF, NIDDK, UK MRC and UK NIHR scientific review panels and as a member of a Diabetes & Neuropathic pain Review Group for the National Institute for Clinical Excellence (NICE).